Aspire Biopharma (NASDAQ:ASBP) Rating Lowered to Strong Sell at Wall Street Zen
Aspire Biopharma (NASDAQ:ASBP – Get Free Report) was downgraded by investment analysts at Wall Street Zen to a “strong sell” rating in a research report issued to clients and investors on Saturday. Aspire Biopharma Price Performance ASBP opened at $0.43 on Friday. About Aspire Biopharma (Get Free Report) Aspire Biopharma Holdings, Inc, early-stage biopharmaceutical company, […]
Aspire Biopharma (NASDAQ:ASBP – Get Free Report) was downgraded by investment analysts at Wall Street Zen to a “strong sell” rating in a research report issued to clients and investors on Saturday. Aspire Biopharma Price Performance ASBP opened at $0.43 on Friday. About Aspire Biopharma (Get Free Report) Aspire Biopharma Holdings, Inc, early-stage biopharmaceutical company, […]
